Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathological parameters

Anticancer Research

Volumn 23, Issue 1 B, 2003, Pages 729-732

  Bodner, Klaus ^a   Bodner Adler, Barbara ^a   Kimberger, Oliver ^a   Czerwenka, Klaus ^a   Leodolter, Sepp ^a   Mayerhofer, Klaus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Estrogen receptors; Progesterone receptors; Uterine leiomyosarcomas

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEIOMYOSARCOMA; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE NEOPLASMS;

EID: 0037231185     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Zaloudek CJ and Norris HJ: Mesenchymal Tumors of the Uterus. In: Blaustein's Pathology of the Female Genital Tract, Kurman RJ (eds): Springer Verlag, New York, pp 849-914, 1994.
2. Schwartz Z, Dgani R, Lancet M and Kessler I: Uterine sarcoma in Israel: A study of 104 cases. Gynecol Oncol 20: 354-363, 1985.
3. Evans HL, Chawla SP, Simpson C and Finn KP: Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer 62: 2239-2247, 1988.
4. Nordal RR, Kristensen GB, Kaern J, Stenwig AE, Pettersen EO and Trope CG: The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma. Acta Oncol 34: 797-802, 1995.
5. Van Dinh T and Woodruff JO: Leiomyosarcoma of the uterus. Am J Obstet J Gynecol 144: 817-823, 1982.
6. Silverberg SG: Leiomyosarcoma of the uterus. A clinicopathologic study. Obstet Gynecol 38: 613-628, 1971.
7. Montague A, Swartz DP and Woodruff JD: Sarcoma arising in leiomyoma of the uterus. Am J Obstet Gynecol 92: 421-427, 1965.
8. Buttram VC and Reiter RC: Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 36: 433-445, 1981.
9. Kawaguchi K, Fujii S, Konishi I, Nanbu Y, Nonokaki H and Mori T: Mitotic activity in uterine leiomyoma during the menstrual cycle. Am J Obstet Gynecol 160: 637641, 1989.
10. Kawaguchi K, Fujii S, Konishi I et al.: Immunhistochemical analysis of oestrogen receptors, progesterone receptors and KI-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy. Virchows Arch Pathol Anal 419: 309-315, 1991.
11. Brandon DD, Bethea CL, Strawn EJ et al.: Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. Am J Obste Gynecol 169: 78-85, 1993.
12. Zhai YL, Kobayashi Y, Mori A, Orii A, Nikaido T, Konishi I and Fujii S: Expression of steroid receptors, KI-67, and p53 in uterine leiomyosarcomas. Int J Gynecol Pathol 18: 20-28, 1999.
13. Mittal K and Demopoulos RI: MIB-1 (KI-67), p 53, estrogen receptor, and pragesterone receptor expression in uterine smooth muscle tumors. Human Pathol 32(9): 984-987, 2001.
14. Lantta M, KtIfttlinen J, Wahlstrdm T and Widholm O: Estradiol and progesterone receptors in gynecologic sarcomas. Acta Obste Gynecol Scand 63: 505-508, 1984.
15. Wade K, Hammond I, Williams K and Cauchi M: Uterine sarcoma: steroid receptors and response to hormonal therapy. Gynecol Oncol 39: 364-367, 1990.
16. Sutton GP, Stehman FB, Michael H, Young PC and Ehrlich CE: Estrogen and progesterone receptors in uterine sarcomas. Obstet Gynecol 68: 709-715, 1986.
17. Soper JT, Mc Carthy KS, Hinshaw W, Creasman WT, Mc Carthy KS, Clar-Pearson DL: Cytoplasmic estrogen and progesterone receptor content of uterine sarcomas. Am J Obstet Gynecol 150: 342-348, 1984.
18. Bell SW, Kempson RL and Hendrickson MR: Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 18(6): 535-558, 1994.
19. Kauppilla A, Kujansuu E and Vihko R: Cytosol estrogen and progestin receptors in endometrial carcinoma of patients treated with surgery, radiotherapy and progestin. Clinical correlates. Cancer 20: 2157-2162, 1982.
20. Osborne CK, Yochmowitz MG, Knight WA and Mc Giure WL: The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46: 2884-2888, 1980.
21. Mayerhofer K, Obermair A, Windbichler G, Petru E, Kaider A, Hefler L, Czerwenka K, Leodolter S and Kainz C: Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol 74(2): 196-201, 1999.
22. Vardi JR and Tovell HMM: Leiomyosarcoma of the uterus: Clinicopathologic study. Obstet Gynecol 56: 428-434, 1980.
23. Christopherson WM, Williamson EO and Gray LA: Leiomyosarcoma of the uterus. Cancer 29: 1512-1517, 1972.
24. Cantin J and Me Neer G: The effect of pregnancy on the clinical course of sarcoma of the soft somatic tissues. Surg Gynecol Obstet 125: 28-32, 1967.